[1] CASTANEDA J A, LIM M J, COOPER J D, et al. Immune system irregularities in lysosomal storage disorders. Acta Neuropathol, 2008, 115(2): 159-174. [2] PANDEY M K, GRABOWSKI G A. Immunological cells and functions in Gaucher disease. Crit Rev Oncog, 2013, 18(3): 197-220. [3] RIGANTE D, CIPOLLA C, BASILE U, et al. Overview of immune abnormalities in lysosomal storage disorders. Immunol Lett, 2017, 188: 79-85. [4] ZAHRAN A M, ELTAYEB A A, ELSAYH K I, et al. Activated and memory T lymphocytes in children with Gaucher disease. Arch Immunol Ther Exp (Warsz), 2017, 65(3): 263-269. [5] MARODI L, KÁPOSZTA R, TÓTH J, et al. Impaired microbicidal capacity of mononuclear phagocytes from patients with type I Gaucher disease: partial correction by enzyme replacement therapy. Blood, 1995, 86(12): 4645-4649. [6] DULGAR O, ESKAZAN A E, ERSEN E, et al. Pleural tuberculosis in a patient with untreated type 1 Gaucher disease. J Infect Chemother, 2016, 22(1): 53-57. [7] PAN J, SUN Z Y, JI C, et al. A case of unusual association of Gaucher's disease with spinal tuberculosis. Int J Rheum Dis, 2013, 16(3): 361-363. [8] LUKINA E A, MAMONOV V E, LUKINA K A, et al. Tuberculous sacroiliitis in a patient with Gaucher disease. Ter Arkh, 2013, 85(7): 87-89. [9] 中华医学会儿科学分会遗传代谢内分泌学组, 中华医学会儿科学分会血液学组, 中华医学会血液学分会红细胞疾病(贫血)学组. 中国戈谢病诊治专家共识(2015). 中华儿科杂志, 2015, 53(4): 256-261. [10] BARRANGER JA, O'ROURKE E. Lessons learned from the development of enzyme therapy for Gaucher disease. J Inherit Metab Dis, 2001, 24(Suppl 2): 89-96, discussion 87-88. [11] Mor A, Philips MR. Compartmentalized Ras/MAPK signaling. Annu Rev Immunol, 2006, 24: 771-800. [12] KOLCH W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol, 2005, 6(11): 827-837. [13] FINKELSTEIN R, NACHUM Z, REISSMAN P, et al, Anaerobic osteomyelitis in patients with Gaucher's disease. Clin Infect Dis, 1992, 15(5): 771-773. [14] BEUTLER E, KUHL W. The diagnosis of the adult type of Gaucher's disease and its carrier state by demonstration of deficiency of beta-glucosidase activity in peripheral blood leukocytes. J Lab Clin Med, 1970, 76(5): 747-755. [15] BERG R D, LEVITTE S, O'SULLIVAN M P, et al. Lysosomal disorders drive susceptibility to tuberculosis by compromising macrophage migration. Cell, 2016, 165(1): 139-152. [16] AKER M, ZIMRAN A, ABRAHAMOV A, et al. Abnormal neutrophil chemotaxis in Gaucher disease. Br J Haematol, 1993, 83(2): 187-191. |